Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
| Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives |
| Autore | Vermehren Charlotte |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (224 p.) |
| Soggetto topico |
Manufacturing industries
Medicine and Nursing |
| Soggetto non controllato |
2019 Beers criteria
5'nuclease assay 80 and over abacavir acute kidney injury adverse drug reaction adverse drug reactions aged allopurinol antidepressants antiepileptic drugs antipsychotics appropriateness bleeding children chronic clinical pharmacist clozapine CNV copy number variation cost-effectiveness CYP1A2 CYP2D6 CYP2D7P CYP2D8P cytochrome P450 cytochromes deprescribing deprescriptions determinants digital decision-support digital health DOACs drug hypersensitivity drug information service drug interaction checkers drug metabolization drug-drug interactions drug-gene interactions early biomarker electronic medical record electronic prescribing emergency department Ethiopia exosomes extracellular vesicles flucloxacillin general practice genotyping health outcomes health services research high resolution melting HLA hospital pharmacy service HRM loxapine medication adherence medication optimization medication reconciliation medication review medication-based risk score microvesicles multimorbidity nursing homes olanzapine older adults older patients outpatient personalized medicine persons with diabetes pharmacogene expression pharmacogenetics pharmacogenomics phenprocoumon plasma neutrophil gelatinase-associated lipocalin polypharmacy population-based potentially inappropriate medication use prevalence process evaluation quality of life shared medication record SLCO1B1 soluble urokinase plasminogen activator receptor thromboembolism utility youth |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy |
| Record Nr. | UNINA-9910595072903321 |
Vermehren Charlotte
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Gluten-Related Disorders: Time to Move from Gut to Brain
| Gluten-Related Disorders: Time to Move from Gut to Brain |
| Autore | Hoggard Nigel |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (158 p.) |
| Soggetto topico |
Biology, life sciences
Food & society Research & information: general |
| Soggetto non controllato |
anti-GAD antibodies
anti-gliadin antibodies anxiety ataxia attention deficit hyperactivity disorder autism spectrum disorder autistic spectrum disorder autoimmune thyroid disease autoimmunity bipolar disorder celiac disease cerebellar ataxia coeliac disease cognition cortical excitability depression dermatitis herpetiformis disease duration duodenal lymphocytosis eating disorders encephalopathy executive dysfunction food intolerance gamma-amino-butyric acid gliadin gluten gluten ataxia gluten encephalopathy gluten free diet gluten neuropathy gluten sensitivity gluten-free diet gluten-related pathology headaches HLA irritable bowel syndrome MR imaging multiple food hypersensitivity multiple sclerosis myopathy neurological disorders neurological dysfunction neurology neuropathy neuropsychiatric symptoms non-celiac wheat sensitivity psoriasis psychiatric manifestations review schizophrenia stiff person syndrome TG2 TG3 TG6 TG6 antibodies transcallosal inhibition transcranial magnetic stimulation transglutaminase antibodies type 1 diabetes |
| ISBN | 3-0365-5060-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Gluten-Related Disorders |
| Record Nr. | UNINA-9910619467903321 |
Hoggard Nigel
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacogenetics to Avoid Adverse Drug Reactions
| Pharmacogenetics to Avoid Adverse Drug Reactions |
| Autore | López-Fernández Luis A |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (220 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
(es)citalopram
5-fluorouracil acute coronary syndrome adverse drug reactions adverse events allele anti-epileptic drugs (AEDS) antiepileptics antipsychotic agents atorvastatin capecitabine cardiology cardiovascular disease clinical implementation clopidogrel colorectal cancer cutaneous adverse drug reaction cutaneous adverse drug reactions (CADRs) CYP2C9*3 CYP450 enzymes cytochrome P-450 enzyme system direct oral anticoagulants drug-drug-gene-interaction drug-drug-interaction drug-gene-interaction epistasis fluoropyrimidine genetic polymorphism genetic risk factors genotype guidelines HLA HLA B India n/a personalised medicine pharmacogenetics pharmacogenomics phenytoin (PHT) platelet reactivity polymorphism precision medicine psychotic disorders random forest SCAR single-nucleotide variants SLCO1B1 South India statin the PharmLines initiative thymidylate synthase thymidylate synthase enhancer region toxicity upstream stimulatory factor 1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557610103321 |
López-Fernández Luis A
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||